# Fraud, Related Parties and Warning Signs in Corporate Venture Capital | KEZ$

Canonical: https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital
Language: en-US

Assess fraud, conflicts and related parties in corporate venture capital through pilot controls, intellectual property diligence and governance.

[Corporate Venture Capital: diligence and governance](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)

# Fraud, Related Parties and Warning Signs in Corporate Venture Capital

Assess fraud, conflicts and related parties in corporate venture capital through pilot controls, intellectual property diligence and governance.

KEZS team · Educational guide

[Corporate Venture Capital](https://kezs.com.br/en/learn?tag=Corporate%20Venture%20Capital)[Governance](https://kezs.com.br/en/learn?tag=Governance)[Fraud](https://kezs.com.br/en/learn?tag=Fraud)[Related Parties](https://kezs.com.br/en/learn?tag=Related%20Parties)[Internal Sponsorship](https://kezs.com.br/en/learn?tag=Internal%20Sponsorship)[Intellectual Property](https://kezs.com.br/en/learn?tag=Intellectual%20Property)[Commercial Independence](https://kezs.com.br/en/learn?tag=Commercial%20Independence)

[← Corporate Venture Capital: diligence and governance](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)[1. Risk begins when the strategic thesis replaces verification](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-1)[2. Separate equity, debt and commercial procurement](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-2)[3. Internal sponsorship needs authority, boundaries and continuity](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-3)[4. Map related parties beyond the organisation chart](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-4)[5. Circular revenue and manufactured traction](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-5)[6. Evidence needs provenance, scope and the ability to be challenged](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-6)[7. Design the pilot to learn without purchasing a conclusion](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-7)[8. Numerical example: keep equity and the pilot in separate accounts](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-8)[9. Cash timing and the consequences of stopping](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-9)[10. Intellectual property: establish who can deliver what is promised](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-10)[11. Commercial independence and the cost of exclusivity](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-11)[12. Governance must address conflicts, not merely record them](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-12)[13. Turn disagreements into verifiable negotiating conditions](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-13)[14. Adverse scenarios and responses to suspected fraud](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-14)[15. Correct assessment errors without erasing the record](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-15)[16. Organise the project record and make an accountable decision](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#topic-16)[Frequently asked questions](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#faq)[References](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/fraud-related-parties-and-warning-signs-in-corporate-venture-capital#references)

What you will find 

In corporate venture capital, or CVC, the same corporation can be an investor, customer, data provider and gateway to other buyers. This proximity gives a startup access to expertise and resources that may otherwise be difficult to obtain. It also creates ambiguity: enthusiasm from an innovation team may be presented as proven demand, an experimental purchase may support an equity valuation, and an executive's interest may look like an institutional commitment. The investor must identify the independent facts supporting each interpretation.

01 

## Risk begins when the strategic thesis replaces verification

Fraud involves deliberate deception, but diligence should not begin by assuming that every inconsistency is intentional. Accounting mistakes, commercial optimism, weak controls and conflicts of interest can produce similar warning signs. Record the claim, identify who benefits, seek verifiable evidence and assess the economic consequences if it proves false. A startup can have working technology while overstating revenue. An internal sponsor can support a legitimate pilot while concealing a relevant personal relationship. One credible component does not validate the entire transaction.

The innovation thesis should identify the corporate problem, the learning sought and the conditions for investing. Reducing the time needed for an operational analysis is a hypothesis. A reproducible measurement using a suitable sample and known costs is evidence. Moving between them requires a method, access and accountable people. When strategic enthusiasm bypasses this work, it becomes harder to distinguish a technology investment from an arrangement that transfers resources, benefits connected parties or manufactures attractive indicators.

02 

## Separate equity, debt and commercial procurement

Equity investment acquires ownership rights and exposes capital to the company's performance and governing terms. A loan creates contractual payment obligations, with default and enforcement risks. A commercial contract pays for delivery, licensing or services. A convertible instrument can change its treatment and economic position under specified events and clauses. These arrangements may coexist, but each needs its own return analysis. Buying from an investee does not recover the equity investment, and sales revenue does not automatically become a payment to shareholders.

Keep this distinction visible in contracts, cost centres and approvals. The pilot agreement should define scope, price, acceptance, data use and responsibilities. Investment documents establish ownership, governance, information rights and economic conditions. Any loan requires its own repayment schedule and analysis. Cross-linked clauses deserve scrutiny: making investment conditional on a purchase may be legitimate, but the parties must explain who bears the cost and whether the commercial price remains defensible without the incentive to complete the equity transaction.

The structure must also fit its participants under Brazilian rules. A business cannot admit equity partners while remaining a MEI merely by signing a participation agreement. A donation to a nonprofit creates neither equity ownership nor a promised financial return. Rights over existing, eligible receivables differ from expectations of future sales. These distinctions prevent one relationship from being labelled as another to imply rights, security or exit options it does not provide. They also determine which documents and professional checks are necessary.

03 

## Internal sponsorship needs authority, boundaries and continuity

An internal sponsor connects a solution to a real problem, mobilises specialists and helps remove operational obstacles. That support does not automatically represent approval from procurement, security, legal or investment teams. A useful mandate identifies the responsible department, available budget, staff time and limits of authority. If the sponsor can recommend but cannot sign a contract, that distinction must be explicit. Corporate branding in a presentation and favourable messages from an executive do not establish purchasing authority.

Diligence should establish how the sponsor met the founders and whether there are family ties, financial interests, paid referrals or personal performance incentives. Extend the inquiry to intermediaries and suppliers recommended for the pilot. A connection does not establish misconduct; concealing a material connection undermines confidence in the process. Disclosures should be updated and checked against relevant documents, with appropriate privacy protections. A signed form alone cannot exclude an interest held through another person or company.

The project should also survive the sponsor's departure or change of role. Identify an operational replacement and check whether the department still considers the problem a priority. If continuity depends on one person, commercial forecasts must reflect that weakness. Pressure to close before a reorganisation, resistance to involving the budget owner, or insistence on hiring the sponsor's chosen consultant are warning signs. They justify further verification and fewer irreversible commitments until the dependency is understood; they do not, by themselves, prove fraud.

04 

## Map related parties beyond the organisation chart

Related parties can appear on either side: founders, directors, businesses under common control, family members with significant influence and vehicles holding economic interests. Diligence should also identify connections that may impair independence even where their legal or accounting classification requires specialist assessment. The aim is not to label every acquaintance a related party. It is to establish who can influence a decision, receive an undisclosed benefit or make a transaction appear independent when it is not.

A practical map links people, companies, contracts and payments. For each material relationship, record who controls the counterparty, what was delivered, how the price was set and who approved it. Examine consultants paid soon after investment, distributors generating substantial sales and companies owning essential technology. A startup may appear independent while its revenue, workforce and software depend on entities controlled by the same founders but excluded from the business in which the investor acquires an interest. Ownership in one company does not automatically capture value held elsewhere.

Investigations should use legitimate methods and remain proportionate to risk. Corporate records, contracts, disclosures and authorised confirmations become more useful when checked against one another. A shared address or surname is a reason to clarify, not sufficient proof. A relationship may be acceptable with disclosure and controls, or require restructuring before investment. If the recipients of significant payments remain unidentified, the gap is economic as well as documentary: the investor cannot reliably assess where capital goes or what benefits the investment actually acquires.

05 

## Circular revenue and manufactured traction

A particular CVC risk is fabricated demand that appears to validate the strategic thesis. A startup may show contracts, invoices and receipts while returning money to the buyer through consultancy fees, side discounts or a connected supplier. Alternatively, investment proceeds may fund a counterparty that then purchases from the startup. Money moves without equivalent independent demand. Bank reconciliation confirms receipt, but cannot alone establish the ultimate source of funds, the substance of the service or associated outgoing payments.

Suppose hypothetical historical revenue is R$ 1.2 million, including R$ 300,000 attributed to a distributor connected to a founder. Review the contract, delivery, payment capacity, actual collection and any repurchase or reimbursement obligations. Without adequate confirmation, show the R$ 300,000 as unconfirmed in the analysis. This does not establish fraud, but prevents the entire amount from being described as proven external demand. Removing it in a sensitivity analysis leaves R$ 900,000; that arithmetic does not automatically validate the remaining revenue, which still needs appropriate checks.

Useful tests connect sales, usage and cash: who uses the solution, accepts delivery and pays, and whether refunds or linked expenses exist. A large customer may have purchased only a small departmental experiment. A signed agreement may contain no minimum purchase obligation. Recurring use and renewals help establish traction, but require context. Where evidence depends on buyers connected to the funding round, recalculate concentration, margin and commercial independence before negotiating valuation. Transaction volume alone cannot resolve these questions.

06 

## Evidence needs provenance, scope and the ability to be challenged

An orderly document collection can still mislead when everything comes from one source. A founder's presentation, spreadsheet and recommendation letter are not three independent confirmations. Record each item's origin, coverage period, limitations and reviewer. Connect contracts to deliveries and obligations, statements to transactions, and technical metrics to the environment and measurement method. Another reviewer should be able to reconstruct the conclusion without relying on the original analyst's memory. Unexplained gaps should remain visible rather than being smoothed over in the final presentation.

External confirmation requires an authorised purpose and a contact with the knowledge and authority to verify the fact, reached through an authenticatable channel. A forwarded message is weaker than a direct response from the responsible department. Ask precise questions: payment confirmation does not establish satisfaction; confirmation of a test does not establish scalability; interest does not establish an approved budget. Preserve those boundaries even when the response supports the transaction. A helpful customer reference should not be expanded into claims the customer never confirmed.

Private documents need restricted access, sharing records and retention appropriate to their purpose. Personal data and trade secrets should not circulate freely across the corporation or be placed on a public blockchain. A cryptographic record may help verify the integrity of a particular version, but does not prove truth, legal ownership, reserve solvency or payment. Recording technology supplements the evidence trail; it cannot establish who had authority to create or sign a document, whether its underlying transaction occurred, or what rights can actually be enforced.

07 

## Design the pilot to learn without purchasing a conclusion

A credible pilot starts before the demonstration. The user department defines the problem, comparison baseline and criteria for success, failure and stopping. If the aim is less rework, specify how it will be measured, which activities count and who validates the result. Selecting only easy cases can produce accurate sample results that misrepresent ordinary operations. Document exclusions, conditions of use and differences between the experimental setting and a possible full deployment. Those limits determine how far the findings can reasonably support a purchase or investment.

Access to corporate specialists is a real CVC advantage, provided its cost is recognised. A solution requiring daily support from corporate engineers may be uneconomic without that assistance. Internal hours, integration, security review and process changes belong in the buyer's assessment. Unpaid founder work can similarly distort the startup's margin. Separate technical performance, full implementation cost and repeatability for customers with fewer resources. A working prototype and a commercially repeatable service answer different questions and may justify different next steps.

Acceptance should be documented by the person accountable for use, with suitable technical input and previously agreed criteria. Changing a target after observing results requires justification and preservation of the original measurement. A pilot may justify more testing without justifying investment, or justify procurement without equity ownership. Operational failure may still produce useful learning. Calling every outcome a strategic success removes the experiment's control function and can allow commercial spending to support a valuation that the evidence does not sustain.

08 

## Numerical example: keep equity and the pilot in separate accounts

Assume a fictional startup receives R$ 3 million in equity funding at a R$ 12 million pre-investment valuation and R$ 15 million post-investment valuation. With a simplified direct issuance and no other instruments, options or rights affecting the calculation, the investor owns 20%. The corporation also purchases a R$ 240,000 pilot, with forecast direct costs of R$ 180,000 for the startup. The R$ 60,000 difference is a commercial contribution before other expenses and taxes. It is not a R$ 60,000 investment return paid to the shareholder.

Now suppose a future sale leaves R$ 20 million actually distributable to shareholders, with no dilution, preferences, outstanding debt or other adjustments. A 20% holding receives R$ 4 million: R$ 1 million above the original contribution, before applicable costs and taxes. If only R$ 5 million is distributable, the holding receives R$ 1 million and loses R$ 2 million of invested capital. These are hypothetical arithmetic exercises, not forecasts. Neither scenario automatically reimburses the equity investor for the pilot purchase. Actual distribution rights must be read in the governing documents.

Assess procurement in parallel. The buyer spends R$ 240,000 and must judge whether delivery and learning justify that expenditure. The startup earns revenue against specific obligations. A free trial cannot be presented as contracted revenue, and a future purchase awaiting budget approval remains a hypothesis. The committee should first understand the two decisions separately, then examine their interaction: investment can influence willingness to buy, while buying can create the appearance of traction used to support investment. Combining the accounts would conceal both incentives and costs.

09 

## Cash timing and the consequences of stopping

Continue the example with R$ 300,000 in cash before investment. Receiving R$ 3 million at the outset produces an opening balance of R$ 3.3 million. The four-month pilot pays R$ 80,000 in month one, R$ 80,000 in month two and R$ 80,000 in month four. Direct costs are R$ 45,000 monthly, totalling R$ 180,000. Other paid expenses are R$ 180,000 per month. To isolate the arithmetic, assume no other receipts, payments or tax effects during this period. All amounts are hypothetical planning assumptions.

In month one, R$ 3.3 million plus R$ 80,000 minus R$ 225,000 leaves R$ 3.155 million. Month two ends at R$ 3.010 million; month three, with no pilot receipt, at R$ 2.785 million; month four at R$ 2.640 million. Net cash consumption is R$ 660,000: R$ 900,000 in total expenses less R$ 240,000 collected. The pilot makes a positive direct contribution but does not cover the company's wider cost base. A presentation using the experiment's margin to imply company-wide financial sustainability would therefore overstate what these figures show.

Suppose the pilot stops after month three, eliminating the final payment and all R$ 45,000 of month-four direct costs. With other assumptions unchanged, closing cash is R$ 2.605 million, R$ 35,000 below the original case: R$ 80,000 of receipts lost less R$ 45,000 saved. If those costs are already committed and unavoidable, cash ends at R$ 2.560 million. Contract terms determine which case is relevant. Neither calculation includes possible compensation or collection claims; these need separate assessment and cannot be treated as certain cash.

10 

## Intellectual property: establish who can deliver what is promised

Technology can work without belonging to the company receiving investment. Contractor-written code, assets created during earlier employment, licensed components and research involving third parties all require checks on ownership and permitted use. Understand the documentary chain for essential assets and any restrictions. A broad founder declaration does not repair gaps in specific agreements. The economic question is whether the company can exploit, maintain, modify and commercialise the solution on the terms used to support its valuation. Access to code alone does not answer all of those questions.

The pilot adds another layer: pre-existing knowledge, customer-specific adaptations and jointly produced results need distinct treatment. Corporate exclusivity over all development could restrict future sales. A narrow licence could leave the buyer dependent on a supplier without adequate maintenance arrangements. Define permitted uses, relevant territory, duration, access and continuity. Distinguish customer-provided data from derived results and specify permissions for model training or product improvement. A permission covering delivery of the pilot should not be assumed to cover every subsequent use of the same information.

Conflict arises when an executive seeks extensive commercial rights while the investment committee values the startup as a scalable, independent business. Those assumptions may be incompatible. Reflect the restrictions actually agreed in both price and investment thesis before closing. If a related company owns essential intellectual property, an appropriate assignment or licence may be an investment condition, subject to legal review. If regularisation is impossible, assess the dependency explicitly. A promise to transfer an asset must not be valued as though the company already owns it.

11 

## Commercial independence and the cost of exclusivity

A corporation may seek competitive advantage while a startup needs multiple customers to scale. Exclusivity, commercial preference and restrictions on serving competitors can initially align interests and later separate them. The task is to measure scope and compensation, not automatically reject every restriction. A broad market limitation without minimum purchasing commitments can block sales without generating replacement revenue. Strategic value captured by the corporation may then reduce the economic value of the equity stake it has acquired. Both effects belong in the decision.

Commercial independence includes the ability to refuse poor business. An investee may be pressed to grant discounts, customisation or extended payment terms to improve the sponsoring unit's indicators. Accepting terms it would reject from an independent customer transfers value from the company to its shareholder-customer. Make that transfer visible to other shareholders. Price comparisons must account for scope, volume, risk and support: different prices do not establish favouritism. An inconsistent explanation, however, warrants review, particularly where the interested buyer influences the approval process.

Monitoring should examine revenue concentration and the ability to sell without the sponsor's brand. Several contracts can still depend on one economic group. Corporate introductions may open doors, but are not acquired customers. Separate firm orders from negotiations and possibilities. If future independence is central to the thesis, the commercial plan must explain how independent buyers will be reached, who funds that effort and which contractual restrictions could prevent expansion. A pipeline supported by introductions remains uncertain until the relevant purchasing decisions and commitments are established.

12 

## Governance must address conflicts, not merely record them

A robust process allocates substantive responsibility. The user department owns the problem and operational acceptance; specialists assess performance and limitations; procurement reviews commercial terms; legal and privacy teams assess contracts, data and rights; finance checks assumptions and cash; the investment committee decides on capital. Roles can vary, but someone must answer for each conclusion. The sponsor supplies context and access without becoming the sole validator of their own recommendation. More signatures add little protection if no one understands what they are confirming.

A material conflict disclosure should have consequences. Depending on the structure and applicable analysis, these may include recusal, independent advice, approval by disinterested decision-makers or additional conditions. Minutes that mention the conflict while allowing the interested person to select all evidence and decide alone provide little protection. Record the information considered, alternatives discussed and reasons the decision remains defensible. A person excluded from voting may still provide technical information, provided that contribution is distinguished from authority to approve and is open to appropriate challenge.

Post-investment governance should cover related-party transactions, changes to essential assets and material departures from the intended use of capital. It need not require approval of every minor purchase. Proportionate materiality criteria and sufficient information matter more. Excessive rights can paralyse the company; vague rights can prevent a response to diversion of funds. Negotiate workable detection and response powers, considering control costs, team size and the possibility that the investor is itself conflicted as a customer. Controls must be usable when an uncomfortable transaction actually arises.

13 

## Turn disagreements into verifiable negotiating conditions

Disagreements between innovation, procurement and investment teams are expected. Users may see immediate operational gains, investors may see dependency and a high valuation, and founders may fear losing autonomy. Turn positions into testable assumptions. If innovation claims a pilot opens a market, identify other buyers sharing the problem and what remains untested. If procurement demands exclusivity, explain the benefit and cost. If founders price the business on expansion, show how much depends on unsigned contracts. This makes differences assessable without pretending that every department seeks the same outcome.

Conditions should respond to identified risks. An ownership gap may require correction before funding. Uncertain revenue may call for independent confirmation and a revised valuation. Sponsor dependency may justify waiting for institutional responsibility and an approved budget. Staged funding needs objective criteria, clear responsibilities and rules for scope changes. Targets controlled solely by the investor, such as its own purchasing volume, can create unequal bargaining power and incentives to manipulate measurement. A milestone offers little clarity if one party can determine whether it is met without an objective basis.

Representations, contractual warranties and remedies can help, but depend on wording, enforceability and the obligor's ability to respond. They do not replace verification of an essential asset. A stronger signature cannot supply missing ownership documents or assets available to cover losses. Reducing the commitment, narrowing the pilot or declining investment may be appropriate. Negotiation need not eliminate uncertainty; it should establish which risks remain, who bears them and whether the transaction still makes sense. A contractual remedy is an option to pursue, not a promise of recovery.

14 

## Adverse scenarios and responses to suspected fraud

Suppose a significant payment to a consultancy connected to the internal sponsor emerges after investment. Compare it with the budget, contract, delivery and conflict disclosures. It may reflect legitimate work omitted through a process failure, or a charge without substance. Preserve evidence and involve people without conflicting interests, using restricted access. Avoiding premature accusations does not require continuing disbursements without criteria. Any suspension of payments, access or project stages depends on the applicable rules and contractual instruments. Establish the available authority before assuming a particular response can be imposed.

Another scenario is undisclosed human intervention behind demonstrated technical performance. The product may remain useful, but margin, capacity and scalability require recalculation. Repeat measurements under a known procedure, identify hidden costs and assess whether the omission was isolated or deliberate. An investor that also purchased the solution should separate the commercial investigation from the equity assessment. Customer acceptance does not resolve questions about fundraising disclosures or consequences for other shareholders. The relevant question is what was represented, what actually occurred and how the difference affected each decision.

Loss can also occur without fraud: a sponsor leaves, a budget is cut, integration fails or a competitor performs better. These events call for reassessment and cash discipline, not automatic allegations. Altered documents, hidden beneficiaries and contradictory payment explanations may justify a more serious investigation. Scale the response to the evidence and exposure. Financial recovery, enforcement of rights and legal action require specific analysis. No control permits an assumption that invested capital will be recovered, and the cost and uncertainty of responding belong in the assessment.

15 

## Correct assessment errors without erasing the record

Common errors include presenting nonrecurring revenue as a stable growth base, attributing results produced by intensive corporate support entirely to the technology, counting a proposal as a contract, or treating investment intentions as available cash. Begin with correct classification, rebuild the assumptions and show the effect on the decision. Changing a word in a presentation without revisiting the economics leaves the underlying distortion intact. The correction should reach the people whose approval, budget or valuation depended on the earlier information, rather than remaining confined to an analyst's revised working file.

In the pilot example, adding the corporation's R$ 240,000 payment to the equity return would be incorrect. Keep the commercial outlay in the buyer's budget, revenue and delivery costs in the startup's accounts, and any equity outcome in the investment analysis. If the spreadsheet has circulated, identify the error, its impact and the recipients who need to reconsider their conclusions. Preserve the history to explain decisions made using the earlier version. Recording a correction does not require exposing personal information or distributing private documents more widely.

Another mistake is treating missing evidence as proof that no problem exists. An unsuccessful search does not establish the absence of connections, and an unqualified report cannot validate matters outside its scope. Record gaps and their practical consequences: accept the risk, obtain evidence, change terms or stop the analysis. Process quality lies in that link between uncertainty and action. A clear conclusion with explicit limitations is more useful than a favourable classification whose method cannot be explained. Unresolved questions should remain visible during subsequent monitoring.

16 

## Organise the project record and make an accountable decision

A project dossier can connect the corporate need, responsible people, instruments and evidence. Include the thesis, relationship map, pilot budget, acceptance criteria, intellectual property position, financial assumptions and outstanding conditions. Every material claim should link to evidence or remain labelled as a hypothesis. KEZS connects entrepreneurial projects and potential funders through technology and intermediation. Organising information this way can help people understand and compare cases. Investors remain responsible for their own diligence and decisions; KEZS does not assign a credit score. Documentation cannot guarantee approval or repayment.

The decision must respect the activity involved. Public securities distribution and regulated financial activities require appropriate structures and providers; technology or a CNAE business activity classification is not permission. Reference entry points for professional analysis include Banco Central materials on banking correspondents, CVM Resolutions 88 and 175, Portal do Empreendedor guidance on MEI, and ANPD guidance. Each has its own scope. None proves KEZS authorisation, the suitability of an offer or any participant's compliance. Their relevance must be assessed for the actual instrument, activities and parties.

Before deciding, explain the problem being tested, who can contract, who benefits, which rights are acquired and what remains unconfirmed. Understand the effects of stopping the pilot, commercial restrictions, ownership gaps and available responses. Revisit these questions when facts change, with revised assumptions and proportionate controls. Strategic usefulness belongs alongside cost, conflicts, uncertainty and possible loss. An accountable decision can be examined and challenged; it does not promise profitability, liquidity or preservation of capital. Clear records support judgment without replacing it.

FAQ 

## Frequently asked questions.

### Should a related-party transaction automatically be rejected?

No. There may be a legitimate economic reason, such as hiring a specialist business connected to a founder. Establish the relationship, verify delivery, compare terms and obtain a decision from people without a conflicting interest. Risk increases when the connection is concealed, pricing lacks justification or choosing another supplier is not practically possible. Disclosure alone does not make an essential transaction acceptable if its substance cannot be verified. The decision should explain both its business rationale and the controls addressing the connection.

### Is a successful pilot enough to justify equity investment?

A pilot can demonstrate performance within a defined scope and provide implementation and cost evidence. Equity investment still requires analysis of price, rights, market, team, intellectual property, capital structure and sustainable selling capacity. A useful solution may require excessive customisation or have a limited market. The committee should identify which risks the pilot reduced and which remain. Commercial acceptance cannot validate the whole company, establish an exit market or guarantee an investment return.

### How can a customer be confirmed without exposing confidential startup information?

Use a defined purpose, appropriate authorisation and a contact competent to confirm the relevant facts. Checking the contract's existence, scope, delivery status and payment may be sufficient without unnecessary personal data or commercial details. Restrict access and record limitations. If information cannot be shared, seek a legitimate alternative or preserve the gap explicitly. Confidentiality does not turn an assertion into a confirmed fact, and confirmation of one point should not be extended to matters the customer did not address.

### What if the internal sponsor demands exclusivity as a condition of supporting investment?

Assess its scope, duration, excluded market and commercial compensation. Exclusivity without minimum purchases may prevent outside revenue and reduce the value of the company and its shares. Compare the corporation's strategic benefit with the cost to the company and other shareholders. Negotiation may narrow the restriction or connect it to verifiable commitments, with legal review of the terms and consequences of breach. Any resulting limits on expansion should also be reflected in the investment thesis and valuation.

### Do weak financial results and inconsistent documents always indicate fraud?

No. A loss-making company can report accurately, while a profitable-looking company can conceal artificial transactions. Examine data origins, explanations, documents and responses to questions. An acknowledged, corrected and traceable mistake warrants different treatment from alterations designed to conceal payments. Consider materiality and exposure, preserve evidence and avoid both unsupported accusations and automatic continuation despite significant warning signs. Commercial failure and deliberate deception can require different responses even when both create financial losses.

### Does a blockchain record make investment documentation trustworthy?

Depending on its technical design, a record may help demonstrate that a registered version has not changed. It does not establish truth, legal title, reserve solvency or the ability to pay obligations. A false contract can have an intact record. Diligence still requires checks on authorship, signing authority, substance and relevant confirmations. Private documents should not be published on public blockchains. Integrity and access control address different problems, and neither alone establishes the economic reality of a transaction.

### Which document should summarise the decision without hiding uncertainty?

An investment memorandum can bring together the thesis, acquired rights, core evidence, material relationships, cash flow, adverse scenarios and outstanding conditions. Distinguish confirmed facts, hypotheses and gaps, and identify responsibility for analysis and monitoring. Explain material disagreements and why remaining risks are acceptable to the decision-makers. The memorandum organises judgment but does not replace contracts, specialist diligence or later verification. It offers no guarantee of repayment, return, liquidity or capital preservation.

## References and context

Institutional reference points for checking applicable rules and guidance. Calculations and scenarios are original examples, not quotes, historical results or individualized recommendations.
- [Banco Central — correspondentes no País ↗](https://www.bcb.gov.br/estabilidadefinanceira/exibenormativo?tipo=Resolu%C3%A7%C3%A3o%20CMN&numero=4935)
- [CVM — Resolução 88, texto e alterações ↗](https://conteudo.cvm.gov.br/legislacao/resolucoes/resol088.html)
- [CVM — Resolução 175, fundos de investimento ↗](https://conteudo.cvm.gov.br/legislacao/resolucoes/resol175.html)
- [Portal do Empreendedor — perguntas sobre MEI ↗](https://www.gov.br/empresas-e-negocios/pt-br/empreendedor/perguntas-frequentes)
- [ANPD — orientações e perguntas frequentes ↗](https://www.gov.br/anpd/pt-br/acesso-a-informacao/perguntas-frequentes)

AI-assisted educational content. Decisions require verification of the information, instruments and providers in each actual case.

## Keep learning.[Explore the category ↗](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)

[

Corporate Venture Capital: diligence and governance 

### Data Rooms and Evidence Quality for Corporate Venture Capital

How corporate venture investors can assess evidence, internal sponsorship and intellectual property while separating pilot results from equity returns.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/data-rooms-and-evidence-quality-for-corporate-venture-capital)

[

Corporate Venture Capital: diligence and governance 

### Cash, Revenue and Execution Capacity in Corporate Venture Capital

Assess cash, revenue and execution in corporate venture capital through pilot economics, internal sponsorship, governance and commercial independence.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/cash-revenue-and-execution-capacity-in-corporate-venture-capital)

[

Corporate Venture Capital: diligence and governance 

### Contracts, Investor Powers and Rights in Corporate Venture Capital

Understand corporate venture capital contracts, investor rights, internal sponsorship, intellectual property and commercial independence in Brazil.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/contracts-investor-powers-and-rights-in-corporate-venture-capital)

From knowledge to decisions 

## Plan your next step with more clarity.[Get started ↗](https://kezs.net/?lang=en)